PANDX Trademark

Trademark Overview

On Wednesday, February 2, 2022, a trademark application was filed for PANDX with the United States Patent and Trademark Office. The USPTO has given the PANDX trademark a serial number of 97250501. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 18, 2025. This trademark is owned by Cyrano Medical, Inc.. The PANDX trademark is filed in the Pharmaceutical Products category with the following description:

diagnostic and test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious disease
pandx

General Information

Serial Number97250501
Word MarkPANDX
Filing DateWednesday, February 2, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2024

Trademark Statements

Goods and Servicesdiagnostic and test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCyrano Medical, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCamden, DE 19934
Party NameCyrano Medical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCamden, DE 19934

Trademark Events

Event DateEvent Description
Tuesday, November 15, 2022ASSIGNED TO EXAMINER
Saturday, February 5, 2022NEW APPLICATION ENTERED
Tuesday, February 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 29, 2022NON-FINAL ACTION WRITTEN
Tuesday, November 29, 2022NON-FINAL ACTION E-MAILED
Tuesday, November 29, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 13, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, June 13, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, June 13, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, July 5, 2023TEAS PETITION TO REVIVE RECEIVED
Wednesday, July 5, 2023PETITION TO REVIVE-GRANTED
Wednesday, July 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 6, 2023NOTICE OF REVIVAL - E-MAILED
Wednesday, December 6, 2023ASSIGNED TO LIE
Wednesday, December 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 28, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 11, 2024FINAL REFUSAL WRITTEN
Thursday, January 11, 2024FINAL REFUSAL E-MAILED
Thursday, January 11, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, May 28, 2024NON-FINAL ACTION WRITTEN
Tuesday, May 28, 2024NON-FINAL ACTION E-MAILED
Friday, November 1, 2024EXAMINERS AMENDMENT E-MAILED
Friday, November 1, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, December 3, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 3, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 14, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 18, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, August 18, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, November 27, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 1, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, November 1, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 6, 2024APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

pandx disease diagnostic fluids detection infectious namely bodily assays kits test